Popular

Cronos Ramps Up: New Spinach Edibles and Vapes Hit Canada
Hemp THC Ban Averted: Congressional Funding Bill Heads to Trump
High Times September 2026: Giraffe P and BBL2 Dominate
Moonbutter Named High Times September 2026 Strain
Green Thumb Targets NYC Capital Summit for Institutional Growth
Curaleaf Hits 76-Store Milestone in Florida

Cronos Ramps Up: New Spinach Edibles and Vapes Hit Canada

Expanding the Spinach Brand: Cronos Group’s Latest Canadian Pivot Cronos Group Inc. (TSX: CRON) is aggressively bolstering its product lineup in the Canadian cannabis market, focusing on innovation within its established Spinach® brand. The company has officially announced the expansion of its portfolio with the launch of a new 100% live resin-infused ‘SOURZ by Spinach®’…

Read More

High Times September 2026: Giraffe P and BBL2 Dominate

High Times columnist David Downs has officially unveiled his highly anticipated “Strains of the Month” for September 2026, marking a significant shift in consumer preferences toward unique, potency-driven genetics. As the legal cannabis market matures, the latest dispensary data highlights two clear winners: “Giraffe P” and “BBL2,” both of which are dominating shelf space and…

Read More

Moonbutter Named High Times September 2026 Strain

As the cannabis industry matures, the spotlight in September 2026 has firmly landed on a singular, potent hybrid that redefines the expectations for high-end craft flower. High Times has officially named ‘Moonbutter’ as its Strain of the Month, a title reserved for cultivars that demonstrate exceptional genetic stability, terpene complexity, and a market-defining aroma. For…

Read More

Curaleaf Hits 76-Store Milestone in Florida

Curaleaf Holdings, Inc. continues to consolidate its dominance in the competitive Florida medical cannabis market, announcing the upcoming launch of its 76th dispensary in the state. Situated in Cutler Bay, this new retail location represents a significant milestone in the company’s ongoing strategy to increase patient accessibility while deepening the penetration of its proprietary brand…

Read More

Endovia Health Eyes Accelerated CannEpil Path Amid DEA Policy Shift

The landscape of pharmaceutical research in the United States is undergoing a tectonic shift. For years, the restrictive classification of cannabis as a Schedule I controlled substance—defined as having a high potential for abuse and no accepted medical use—has created a labyrinthine regulatory environment for pharmaceutical innovators. However, the recent administrative signals from the Drug…

Read More

Luis Guzmán Reigns in ‘The King of Cannabis’ Crime Drama

In a commanding return to the silver screen, veteran actor Luis Guzmán anchors the gritty, true-crime-inspired narrative of ‘The King of Cannabis,’ which made its nationwide theatrical debut on August 28, 2026. The film offers a visceral, unapologetic examination of the high-stakes journey undertaken by an ambitious entrepreneur navigating the volatile, rapidly evolving landscape of…

Read More